1102 related articles for article (PubMed ID: 19790045)
21. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis.
Pacquelet S; Presle N; Boileau C; Dumond H; Netter P; Martel-Pelletier J; Pelletier JP; Terlain B; Jouzeau JY
J Rheumatol; 2002 Dec; 29(12):2602-10. PubMed ID: 12465160
[TBL] [Abstract][Full Text] [Related]
22. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
Neidhart M; Gay RE; Gay S
Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
[TBL] [Abstract][Full Text] [Related]
23. Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect.
Li SY; Cao JL; Shi ZL; Chen JH; Zhang ZT; Hughes CE; Caterson B
J Zhejiang Univ Sci B; 2008 Jan; 9(1):22-33. PubMed ID: 18196609
[TBL] [Abstract][Full Text] [Related]
24. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
25. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
26. The role of cytokines in chondrocyte mediated cartilage degradation.
Shinmei M; Masuda K; Kikuchi T; Shimomura Y
J Rheumatol Suppl; 1989 Aug; 18():32-4. PubMed ID: 2810294
[TBL] [Abstract][Full Text] [Related]
27. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
Hui W; Rowan AD; Richards CD; Cawston TE
Arthritis Rheum; 2003 Dec; 48(12):3404-18. PubMed ID: 14673992
[TBL] [Abstract][Full Text] [Related]
28. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.
Lubberts E; Joosten LA; van de Loo FA; van den Gersselaar LA; van den Berg WB
Arthritis Rheum; 2000 Jun; 43(6):1300-6. PubMed ID: 10857788
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
van de Loo FA; Kuiper S; van Enckevort FH; Arntz OJ; van den Berg WB
Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
[TBL] [Abstract][Full Text] [Related]
30. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage.
Moos V; Fickert S; Müller B; Weber U; Sieper J
J Rheumatol; 1999 Apr; 26(4):870-9. PubMed ID: 10229409
[TBL] [Abstract][Full Text] [Related]
31. Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures.
Jikko A; Wakisaka T; Iwamoto M; Hiranuma H; Kato Y; Maeda T; Fujishita M; Fuchihata H
Cell Biol Int; 1998; 22(9-10):615-21. PubMed ID: 10452831
[TBL] [Abstract][Full Text] [Related]
32. Blood-induced joint damage: a human in vitro study.
Roosendaal G; Vianen ME; Marx JJ; van den Berg HM; Lafeber FP; Bijlsma JW
Arthritis Rheum; 1999 May; 42(5):1025-32. PubMed ID: 10323460
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats.
Chang JK; Chang LH; Hung SH; Wu SC; Lee HY; Lin YS; Chen CH; Fu YC; Wang GJ; Ho ML
Arthritis Rheum; 2009 Oct; 60(10):3049-60. PubMed ID: 19790062
[TBL] [Abstract][Full Text] [Related]
35. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1alpha induction of tensile weakening associated with collagen degradation in bovine articular cartilage.
Temple MM; Xue Y; Chen MQ; Sah RL
Arthritis Rheum; 2006 Oct; 54(10):3267-76. PubMed ID: 17009261
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of hyperosmotic challenge on interleukin-1-activated pathways in bovine articular cartilage.
Le D; Hofbauer MA; Towle CA
Arch Biochem Biophys; 2006 Jan; 445(1):1-8. PubMed ID: 16359637
[TBL] [Abstract][Full Text] [Related]
38. Exposure of cartilage to a fibronectin fragment amplifies catabolic processes while also enhancing anabolic processes to limit damage.
Homandberg GA; Wen C
J Orthop Res; 1998 Mar; 16(2):237-46. PubMed ID: 9621898
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor 1 and corticosteroid modulation of chondrocyte metabolic and mitogenic activities in interleukin 1-conditioned equine cartilage.
Frisbie DD; Nixon AJ
Am J Vet Res; 1997 May; 58(5):524-30. PubMed ID: 9140562
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis by two-dimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor alpha and interleukin-1beta.
Cillero-Pastor B; Ruiz-Romero C; Caramés B; López-Armada MJ; Blanco FJ
Arthritis Rheum; 2010 Mar; 62(3):802-14. PubMed ID: 20131227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
